Start Date
August 31, 2008
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
Maraviroc
Maraviroc 150mg, 300 mg or 600 mg twice daily administered orally with or without food in combination with other antiretroviral agents. The recommended dose of Maraviroc differs based on concomitant medications due to drug interactions as outlined in the Prescribing Information.
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
ViiV Healthcare
INDUSTRY